In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.
Global Market | Is India prepared for a prolonged Middle East oil disruption?
India’s heavy reliance on Middle East crude and relatively low inventory buffers leave it vulnerable to prolonged supply disruptions amid escalating regional tensions. With Brent